Population-based study on use of chemotherapy in men with castration resistant prostate cancer

BACKGROUND. Chemotherapy prolongs life and relieves symptoms in men with castration resistant prostate cancer (CRPC). There is limited information on a population level on the use of chemotherapy for CRPC. MATERIAL AND METHODS. To assess the use of chemotherapy in men with CRPC we conducted a regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lissbrant, Ingela Franck, Garmo, Hans, Widmark, Anders, Stattin, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812701/
https://www.ncbi.nlm.nih.gov/pubmed/23427879
http://dx.doi.org/10.3109/0284186X.2013.770164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812701/
https://www.ncbi.nlm.nih.gov/pubmed/23427879
http://dx.doi.org/10.3109/0284186X.2013.770164

Ejemplares similares